DNA damage in an animal model of maple syrup urine disease

Molecular Genetics and Metabolism

Volumn 106, Issue 2, 2012, Pages 169-174

  Scaini, Giselli ^a,b   Jeremias, Isabela C ^a,b   Morais, Meline O S ^a,b   Borges, Gabriela D ^a   Munhoz, Bruna P ^a   Leffa, Daniela D ^a   Andrade, Vanessa M ^a   Schuck, Patrícia F ^a   Ferreira, Gustavo C ^a   Streck, Emilio L ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina INCT TM   (Brazil)

Author keywords

Antioxidant treatment; Branched chain amino acids; Comet assay; DNA damage; Maple syrup urine disease; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; DEFEROXAMINE; DNA; ISOLEUCINE; LEUCINE; VALINE;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD; BRAIN CORTEX; CHRONIC TOXICITY; COMET ASSAY; CONTROLLED STUDY; CORPUS STRIATUM; DNA DAMAGE; DRUG EFFECT; EXPERIMENTAL MODEL; GENOTOXICITY; HIPPOCAMPUS; MALE; MAPLE SYRUP URINE DISEASE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AMINO ACIDS, BRANCHED-CHAIN; ANIMALS; ANTIOXIDANTS; BRAIN; DISEASE MODELS, ANIMAL; DNA DAMAGE; MALE; MAPLE SYRUP URINE DISEASE; OXIDATIVE STRESS; RATS; RATS, WISTAR;

ACER; ANIMALIA; RATTUS;

EID: 84860916244     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2012.04.009     Document Type: Article

References (43)

1. Chuang D.T., Shih V.E. Maple syrup urine disease (branched-chain ketoaciduria). The Metabolic and Molecular Bases of Inherited Disease 2001, 1971-2005. McGraw- Hill, New York. C.R. Scriver, A.L. Beaudt, W.L. Sly, D. Valle (Eds.).
2. Treacy E., Clow C.L., Reade T.R., Chitayat D., Mamer O.A., Scriver C.R. Maple syrup urine disease: interrelationship between branched-chain amino-, oxo- and hydroxyacids; implications for treatment; associations with CNS dysmyelination. J. Inherit. Metab. Dis. 1992, 15:121-135.
3. Schonberger S., Schweiger B., Schwahn B., Schwarz M., Wendel U. Dysmyelination in the brain of adolescents and young adults with maple syrup urine disease. Mol. Genet. Metab. 2004, 82:69-75.
4. Snyderman S.E., Norton P.M., Roitman E., Holt L.E. Maple syrup urine disease, with particular reference to dietotherapy. Pediatrics 1964, 34:454-472.
5. Funchal C., Rosa A.M., Wajner M., Wofchuk S., Pessoa-Pureur R. Reduction of glutamate uptake into cerebral cortex of developing rats by the branched-chain α-keto acids accumulating in maple syrup urine disease. Neurochem. Res. 2004, 29:747-753.
6. Tavares R.G., Santos C.E.F., Tasca C., Wajner M., Souza D.O., Dutra-Filho C.S. Inhibition of glutamate uptake into synaptic vesicles of rat brain by the metabolites accumulating in maple syrup urine disease. J. Neurol. Sci. 2000, 181:44-49.
7. Halestrap A., Brand M.D., Denton R.M. Inhibition of mitochondrial pyruvate transport by phenylpyruvate and α-ketoisocaproate. Biochim. Biophys. Acta 1974, 367:102-108.
8. Howell R.K., Lee M. Influence of α-keto acids on the respiration of brain in vitro. Proc. Soc. Exp. Biol. Med. 1963, 113:660-663.
9. Land J.M., Mowbray J., Clark J.B. Control of pyruvate and β-hydroxybutyrate utilization in rat brain mitochondria and its relevance to phenylketonuria and maple syrup urine disease. J. Neurochem. 1976, 26:823-830.
10. Pilla C., Cardozo R.F., Dutra-Filho C.S., Wyse A.T., Wajner M., Wannmacher C.M. Creatine kinase activity from rat brain is inhibited by branched-chain amino acids in vitro. Neurochem. Res. 2003, 28:675-679.
11. Sgaravati A.M., Rosa R.B., Schuck P.F., Ribeiro C.A.J., Wannmacher C.M.D., Wyse A.T.S., Dutra-Filho C.S., Wajner M. Inhibition of brain energy metabolism by the α-keto acids accumulating in maple syrup urine disease. Biochim. Biophys. Acta 2003, 1639:232-238.
12. Bridi R., Braun C.A., Zorzi G.K., Wannmacher C.M., Wajner M., Lissi E.G., Dutra-Filho C.S. Alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats. Metab. Brain Dis. 2005, 20:155-167.
13. Bridi R., Latini A., Braun C.A., Zorzi G.K., Wajner M., Lissi E.G., Dutra-Filho C.S. Evaluation of the mechanisms involved in leucine induced oxidative damage in cerebral cortex of young rats. Free Radic. Res. 2005, 39:71-79.
14. Bridi R., Araldi J., Sgarbi M.B., Testa C.G., Durigon K., Wajner M., Dutra-Filho C.S. Induction of oxidative stress in rat brain by the metabolites accumulating in maple syrup urine disease. Int. J. Dev. Neurosci. 2003, 21:327-332.
15. Fontella F.U., Gassen E., Pulrolni V., Wannmacher C.M.D., Klein A.B., Wajner M., Dutra-Filho C.S. Stimulation of lipid peroxidation in vitro in rat brain by the metabolites accumulating in maple syrup urine disease. Metab. Brain Dis. 2002, 17:47-54.
16. Mescka C., Moraes T., Rosa A., Mazzola P., Piccoli B., Jacques C., Dalazen G., Coelho J., Cortes M., Terra M., Regla Vargas C., Dutra-Filho C.S. In vivo neuroprotective effect of l-carnitine against oxidative stress in maple syrup urine disease. Metab. Brain Dis. 2011, 26:21-28.
17. Nakanishi M., Niida H., Murakami H., Shimada M. DNA damage responses in skin biology-implications in tumor prevention and aging acceleration. J. Dermatol. Sci. 2009, 56:76-81.
18. Faust F., Kassie F., Knasmüller S., Boedecker R.H., Mann M., Mersch-Sundermann V. The use of the alkaline comet assay with lymphocytes in human biomonitoring studies. Mutat. Res. 2004, 566:209-229.
19. El-Khamisy S.F., Caldecott K.W. TDP1-dependent DNA single-strand break repair and neurodegeneration. Mutagenesis 2006, 21:219-224.
20. El-Mallakh R.S., Hedges S., Casey D. Digoxin encephalopathy presenting as mood disturbance. J. Clin. Psychopharmacol. 1995, 15:82-83.
21. Powell C.L., Swenberg J.A., Rusyn I. Expression of base excision DNA repair genes as a biomarker of oxidative DNA damage. Cancer Lett. 2005, 229:1-11.
22. Benes F.M., Walsh J., Bhattacharyya S., Sheth A., Berretta S. DNA fragmentation decreased in schizophrenia but not bipolar disorder. Arch. Gen. Psychiatry 2003, 60:359-364.
23. Bridi R., Fontella F.U., Pulrolnik V., Braun C.A., Zorzi G.K., Coelho D., Wajner M., Vargas C.R., Dutra-Filho C.S. A chemically-induced acute model of maple syrup urine disease in rats for neurochemical studies. J. Neurosci. Methods 2006, 155:224-230.
24. Di-Pietro P.B., Dias M.L., Scaini G., Burigo M., Constantino L., Machado R.A., Dal-Pizzol F., Streck E.L. Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration. Neurosci. Lett. 2008, 434:139-143.
25. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantization of low levels of DNA damage in individual cells. Exp. Cell Res. 1988, 175:184-191.
26. Tice R.R., Agurell E., Anderson D., Burlinson B., Hartmann A., Kobayashi H., Miyamae Y., Rojas E., Ryu J.C., Sasaki Y.F. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000, 35:206-221.
27. Collins A.R. The comet assay for DNA damage and repair: principles, applications, and limitations. Mol. Biotechnol. 2004, 26:249-261.
28. Barschak A.G., Sitta A., Deon M., de Oliveira M.H., Haeser A., Dutra-Filho C.S., Wajner M., Vargas C.R. Evidence that oxidative stress is increased in plasma from patients with maple syrup urine disease. Metab. Brain Dis. 2006, 21:279-286.
29. B. Halliwell, J.M.C. Gutteridge, (2001) Oxidative stress: adaptation, damage, repair and death, in: B. Halliwell, J.M.C. Gutteridge (Eds.), Free Radicals in Biology and Medicine, Oxford University Press, Oxford, 2004, pp. 246-350.
30. Martin L.J. DNA damage and repair: relevance to mechanisms of neurodegeneration. J. Neuropathol. Exp. Neurol. 2008, 67:377-387.
31. Myung N.H., Zhu X., Kruman I.I., Castellani R.J., Petersen R.B., Siedlak S.L., Perry G., Smith M.A., Lee H.G. Evidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytes. Age (Dordr.) 2008, 30:209-215.
32. Sitta A., Manfredini V., Biasi L., Treméa R., Schwartz I.V., Wajner M., Vargas C.R. Evidence that DNA damage is associated to phenylalanine blood levels in leukocytes from phenylketonuric patients. Mutat. Res. 2009, 679:13-16.
33. Cooke M.S., Olinski R., Evans M.D. Does measurement of oxidative damage to DNA have clinical significance?. Clin. Chim. Acta 2006, 365:30-49.
34. Culmsee C., Mattson M.P. p53 in neuronal apoptosis. Biochem. Biophys. Res. Commun. 2005, 331:761-777.
35. Evan G., Littlewood T. A matter of life and cell death. Science 1998, 281:1317-1322.
36. Jouvet P., Rustin P., Taylor D.L., Pocock J.M., Felderhoff-Mueser U., Mazarakis N.D., Sarraf C., Joashi U., Kozma M., Greenwood K., Edwards A.D., Mehmet H. Branched chain amino acids induce apoptosis in neural cells without mitochondrial membrane depolarization or cytochrome c release: implications for neurological impairment associated with maple syrup urine disease. Mol. Biol. Cell 2000, 11:1919-1932.
37. Markesbery W.R., Lovell M.A. DNA oxidation in Alzheimer's disease. Antioxid. Redox Signal. 2006, 8:2039-2045.
38. Wang X., Pal R., Chen X.W., Limpeanchob N., Kumar K.N., Michaelis E.K. High intrinsic oxidative stress may underlie selective vulnerability of the hippocampal CA1 region. Mol. Brain Res. 2005, 140:120-126.
39. Wang X., Pal R., Chen X.W., Kumar K.N., Kim O.J., Michaelis E.K. Genome-wide transcriptome profiling of region-specific vulnerability to oxidative stress in the hippocampus. Genomics 2007, 90:201-212.
40. Wang X., Zaidi A., Pal R., Garrett A.S., Braceras R., Chen X.W., Michaelis M.L., Michaelis E.K. Genomic and biochemical approaches in the discovery of mechanisms for selective neuronal vulnerability to oxidative stress. BMC Neurosci. 2009, 10:12.
41. Wilde G.J., Pringle A.K., Wright P., Iannotti F. Differential vulnerability of the CA1 and CA3 subfields of the hippocampus to superoxide and hydroxyl radicals in vitro. J. Neurochem. 1997, 69:883-886.
42. Davídková M., Stísová V., Goffinont S., Gillard N., Castaing B., Spotheim-Maurizot M. Modification of DNA radiolysis by DNA-binding proteins: structural aspects. Radiat. Prot. Dosimetry 2006, 122:100-105.
43. Gillard N., Begusova M., Castaing B., Spotheim-Maurizot M. Radiation affects binding of Fpg repair protein to an abasic site containing DNA. Radiat. Res. 2004, 162:566-571.